731 related articles for article (PubMed ID: 27021328)
1. Berberine Antifungal Activity in Fluconazole-Resistant Pathogenic Yeasts: Action Mechanism Evaluated by Flow Cytometry and Biofilm Growth Inhibition in Candida spp.
da Silva AR; de Andrade Neto JB; da Silva CR; Campos Rde S; Costa Silva RA; Freitas DD; do Nascimento FB; de Andrade LN; Sampaio LS; Grangeiro TB; Magalhães HI; Cavalcanti BC; de Moraes MO; Nobre Júnior HV
Antimicrob Agents Chemother; 2016 Jun; 60(6):3551-7. PubMed ID: 27021328
[TBL] [Abstract][Full Text] [Related]
2. In vitro anti-Candida activity of selective serotonin reuptake inhibitors against fluconazole-resistant strains and their activity against biofilm-forming isolates.
Costa Silva RA; da Silva CR; de Andrade Neto JB; da Silva AR; Campos RS; Sampaio LS; do Nascimento FBSA; da Silva Gaspar B; da Cruz Fonseca SG; Josino MAA; Grangeiro TB; Gaspar DM; de Lucena DF; de Moraes MO; Cavalcanti BC; Nobre Júnior HV
Microb Pathog; 2017 Jun; 107():341-348. PubMed ID: 28411060
[TBL] [Abstract][Full Text] [Related]
3. Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017.
Selb R; Fuchs V; Graf B; Hamprecht A; Hogardt M; Sedlacek L; Schwarz R; Idelevich EA; Becker SL; Held J; Küpper-Tetzel CP; McCormick-Smith I; Heckmann D; Gerkrath J; Han CO; Wilmes D; Rickerts V
Int J Med Microbiol; 2019 Sep; 309(6):151336. PubMed ID: 31444102
[TBL] [Abstract][Full Text] [Related]
4. In vitro Antifungal Effects of Berberine Against
Xie Y; Liu X; Zhou P
Drug Des Devel Ther; 2020; 14():87-101. PubMed ID: 32021094
[TBL] [Abstract][Full Text] [Related]
5. In-vitro activity of dicationic aromatic compounds and fluconazole against Cryptococcus neoformans and Candida spp.
Del Poeta M; Bixel AS; Barchiesi F; Tidwell RR; Boykin D; Scalise G; Perfect JR
J Antimicrob Chemother; 1999 Aug; 44(2):223-8. PubMed ID: 10473229
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a photometric method with standardized methods of antifungal susceptibility testing of yeasts.
Clancy CJ; Nguyen MH
J Clin Microbiol; 1997 Nov; 35(11):2878-82. PubMed ID: 9350751
[TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
[TBL] [Abstract][Full Text] [Related]
8. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the antifungal activity
Holanda MA; da Silva CR; de A Neto JB; do Av Sá LG; do Nascimento FB; Barroso DD; da Silva LJ; Cândido TM; Leitão AC; Barbosa AD; de Moraes MO; Cc B; Júnior HVN
Future Microbiol; 2021 Jan; 16(2):71-81. PubMed ID: 33459560
[No Abstract] [Full Text] [Related]
10. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
[TBL] [Abstract][Full Text] [Related]
11. Synergistic antifungal activity of berberine derivative B-7b and fluconazole.
Li LP; Liu W; Liu H; Zhu F; Zhang DZ; Shen H; Xu Z; Qi YP; Zhang SQ; Chen SM; He LJ; Cao XJ; Huang X; Zhang JD; Yan L; An MM; Jiang YY
PLoS One; 2015; 10(5):e0126393. PubMed ID: 25992630
[TBL] [Abstract][Full Text] [Related]
12. In vitro synergism between berberine and miconazole against planktonic and biofilm Candida cultures.
Wei GX; Xu X; Wu CD
Arch Oral Biol; 2011 Jun; 56(6):565-72. PubMed ID: 21272859
[TBL] [Abstract][Full Text] [Related]
13. [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints].
Calışkan S; Keçeli Özcan S; Cınar S; Corakçı A; Calışkan E
Mikrobiyol Bul; 2011 Oct; 45(4):697-706. PubMed ID: 22090300
[TBL] [Abstract][Full Text] [Related]
14. The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis.
Koselny K; Green J; DiDone L; Halterman JP; Fothergill AW; Wiederhold NP; Patterson TF; Cushion MT; Rappelye C; Wellington M; Krysan DJ
Antimicrob Agents Chemother; 2016 Dec; 60(12):7115-7127. PubMed ID: 27645246
[TBL] [Abstract][Full Text] [Related]
15. [Biofilm production and antifungal susceptibility patterns of Candida species isolated from hospitalized patients].
Demirbileki M; Timurkaynak F; Can F; Azap O; Arslan H
Mikrobiyol Bul; 2007 Apr; 41(2):261-9. PubMed ID: 17682713
[TBL] [Abstract][Full Text] [Related]
16. Activity of VT-1129 against Cryptococcus neoformans clinical isolates with high fluconazole MICs.
Nielsen K; Vedula P; Smith KD; Meya DB; Garvey EP; Hoekstra WJ; Schotzinger RJ; Boulware DR
Med Mycol; 2017 Jun; 55(4):453-456. PubMed ID: 27664991
[TBL] [Abstract][Full Text] [Related]
17. [In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
Rubio Calvo MC; Gil J; Ramírez de Ocáriz I; Benito R; Rezusta A
Rev Esp Quimioter; 2003 Jun; 16(2):227-32. PubMed ID: 12973462
[TBL] [Abstract][Full Text] [Related]
18. In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans.
Pfaller MA; Messer SA; Hollis RJ; Jones RN
Antimicrob Agents Chemother; 2001 Oct; 45(10):2862-4. PubMed ID: 11557481
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
Hagen F; Hare Jensen R; Meis JF; Arendrup MC
Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
[TBL] [Abstract][Full Text] [Related]
20. In vitro antifungal activity of cassia fistula extracts against fluconazole resistant strains of Candida species from HIV patients.
Sony P; Kalyani M; Jeyakumari D; Kannan I; Sukumar RG
J Mycol Med; 2018 Mar; 28(1):193-200. PubMed ID: 28838629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]